Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2022 Filed Oct 6, 2022 20:15 UTC |
McGraner MattSee Remarks
|
PurchaseCommon Stock | 10,000 | $15.44 | $154,400.00 |
DisclosureSEC source: 0001437749-22-023761 · rdgdoc.xml · nonDerivative · entry 1 McGraner Matt · CIK 0001636187 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,763 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.33 to $15.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 4,463 | $23.50 | $104,880.50 |
DisclosureSEC source: 0001437749-22-023182 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 29,300 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 537 | $23.50 | $12,619.50 |
DisclosureSEC source: 0001437749-22-023182 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 19,511 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 18:28 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 6,111 | $23.70 | $144,830.70 |
DisclosureSEC source: 0001437749-22-023076 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 24,837 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 18:28 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 734 | $23.70 | $17,395.80 |
DisclosureSEC source: 0001437749-22-023076 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,974 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,280 | $23.77 | $30,425.60 |
DisclosureSEC source: 0001437749-22-022979 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,726 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 154 | $23.77 | $3,660.58 |
DisclosureSEC source: 0001437749-22-022979 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,240 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 237 | $23.70 | $5,616.90 |
DisclosureSEC source: 0001437749-22-022918 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,446 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 29 | $23.70 | $687.30 |
DisclosureSEC source: 0001437749-22-022918 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,086 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 585 | $23.75 | $13,893.75 |
DisclosureSEC source: 0001437749-22-022854 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,209 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 70 | $23.75 | $1,662.50 |
DisclosureSEC source: 0001437749-22-022854 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,057 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 17:20 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 652 | $23.75 | $15,485.00 |
DisclosureSEC source: 0001437749-22-022800 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,624 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 19, 2022 Filed Sep 20, 2022 17:20 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 78 | $23.75 | $1,852.50 |
DisclosureSEC source: 0001437749-22-022800 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,987 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 18:33 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,428 | $23.85 | $34,057.80 |
DisclosureSEC source: 0001437749-22-022754 · rdgdoc.xml · nonDerivative · entry 4 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,972 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 18:33 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 172 | $23.85 | $4,102.20 |
DisclosureSEC source: 0001437749-22-022754 · rdgdoc.xml · nonDerivative · entry 3 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,909 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 18:33 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,757 | $23.83 | $41,869.31 |
DisclosureSEC source: 0001437749-22-022754 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,544 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 18:33 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 211 | $23.83 | $5,028.13 |
DisclosureSEC source: 0001437749-22-022754 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,737 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 16:30 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 4,287 | $23.90 | $102,459.30 |
DisclosureSEC source: 0001437749-22-022534 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 12,787 F2 · ownership.nature: These shares are held by a trust, of which Mr. Dondero is the beneficiary. Mr. Dondero disclaims beneficial ownership of such shares. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 16:30 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 515 | $23.90 | $12,308.50 |
DisclosureSEC source: 0001437749-22-022534 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,526 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 18:29 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 2,550 | $23.80 | $60,690.00 |
DisclosureSEC source: 0001437749-22-022080 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,011 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:42 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,250 | $23.75 | $29,687.50 |
DisclosureSEC source: 0001437749-22-021926 · rdgdoc.xml · nonDerivative · entry 2 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,461 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 18:42 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,637 | $23.80 | $38,960.60 |
DisclosureSEC source: 0001437749-22-021926 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,211 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:15 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 413 | $23.80 | $9,829.40 |
DisclosureSEC source: 0001437749-22-021670 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,574 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 16:31 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 4,590 | $23.95 | $109,930.50 |
DisclosureSEC source: 0001437749-22-019801 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,161 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 16:31 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 410 | $24.00 | $9,840.00 |
DisclosureSEC source: 0001437749-22-019380 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,571 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 16:34 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 1,132 | $24.80 | $28,073.60 |
DisclosureSEC source: 0001437749-22-016911 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,161 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 17:20 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Purchase8.50% Series A Cumulative Redeemable Preferred Stock | 5,029 | $24.64 | $123,914.56 |
DisclosureSEC source: 0001437749-22-015509 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,029 F1 · ownership.nature: These shares are held by Drugcrafters ("Drugcrafters"). Mr. Dondero is the sole managing member of the general partner of Drugcrafters, and may be deemed to be an indirect beneficial owner of shares held by Drugcrafters. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 08, 2022 Filed May 10, 2022 16:17 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 17,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011749 · rdgdoc.xml · derivative · entry 6 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,115 Underlying: Common Stock · 17,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F7 · derivative.exercise_date: On June 24, 2020, the reporting person was granted 70,231 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F7 · derivative.expiration_date: On June 24, 2020, the reporting person was granted 70,231 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| May 08, 2022 Filed May 10, 2022 16:17 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Exercise / conversionCommon Stock | 17,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011749 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:17 UTC |
Mitts BrianDirector · See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011748 · rdgdoc.xml · derivative · entry 4 Mitts Brian · CIK 0001514845 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,560 Underlying: Common Stock · 5,780 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F2 · derivative.exercise_date: On June 24, 2020, the reporting person was granted 23,121 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F2 · derivative.expiration_date: On June 24, 2020, the reporting person was granted 23,121 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:17 UTC |
Mitts BrianDirector · See Remarks
|
Tax withholdingCommon Stock | 1,668 | $24.02 | $40,065.36 |
DisclosureSEC source: 0001437749-22-011748 · rdgdoc.xml · nonDerivative · entry 2 Mitts Brian · CIK 0001514845 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,670 Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:17 UTC |
Mitts BrianDirector · See Remarks
|
Exercise / conversionCommon Stock | 5,780 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011748 · rdgdoc.xml · nonDerivative · entry 1 Mitts Brian · CIK 0001514845 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:16 UTC |
McGraner MattSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 23,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011747 · rdgdoc.xml · derivative · entry 4 McGraner Matt · CIK 0001636187 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,687 Underlying: Common Stock · 23,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F3 · derivative.exercise_date: On June 24, 2020, the reporting person was granted 95,375 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F3 · derivative.expiration_date: On June 24, 2020, the reporting person was granted 95,375 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:16 UTC |
McGraner MattSee Remarks
|
Tax withholdingCommon Stock | 6,760 | $24.02 | $162,375.20 |
DisclosureSEC source: 0001437749-22-011747 · rdgdoc.xml · nonDerivative · entry 2 McGraner Matt · CIK 0001636187 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,763 Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:16 UTC |
McGraner MattSee Remarks
|
Exercise / conversionCommon Stock | 23,844 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011747 · rdgdoc.xml · nonDerivative · entry 1 McGraner Matt · CIK 0001636187 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| May 08, 2022 Filed May 10, 2022 16:16 UTC |
Goetz MatthewSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 11,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011746 · rdgdoc.xml · derivative · entry 3 Goetz Matthew · CIK 0001636204 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,843 Underlying: Common Stock · 11,922 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F2 · derivative.exercise_date: On June 24, 2020, the reporting person was granted 47,687 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F2 · derivative.expiration_date: On June 24, 2020, the reporting person was granted 47,687 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| May 08, 2022 Filed May 10, 2022 16:16 UTC |
Goetz MatthewSee Remarks
|
Tax withholdingCommon Stock | 3,338 | $24.02 | $80,178.76 |
DisclosureSEC source: 0001437749-22-011746 · rdgdoc.xml · nonDerivative · entry 2 Goetz Matthew · CIK 0001636204 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,507 Read SEC document |
| May 08, 2022 Filed May 10, 2022 16:16 UTC |
Goetz MatthewSee Remarks
|
Exercise / conversionCommon Stock | 11,922 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011746 · rdgdoc.xml · nonDerivative · entry 1 Goetz Matthew · CIK 0001636204 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:15 UTC |
Sauter Dennis Charles JrGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-011744 · rdgdoc.xml · derivative · entry 2 Sauter Dennis Charles Jr · CIK 0001803863 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890 Underlying: Common Stock · 1,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F2 · derivative.exercise_date: On June 24, 2020, the reporting person was granted 5,780 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F2 · derivative.expiration_date: On June 24, 2020, the reporting person was granted 5,780 restricted stock units. The restricted stock units vested one-fourth on June 24, 2021 and one-fourth on May 8, 2022, and will vest one-fourth on May 8, 2023 and one-fourth on May 8, 2024. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| May 08, 2022 Filed May 10, 2022 20:15 UTC |
Sauter Dennis Charles JrGeneral Counsel
|
Exercise / conversionCommon Stock | 1,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011744 · rdgdoc.xml · nonDerivative · entry 1 Sauter Dennis Charles Jr · CIK 0001803863 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:02 UTC |
LAFFER ARTHUR BDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004226 · rdgdoc.xml · derivative · entry 3 LAFFER ARTHUR B · CIK 0001090307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,958 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F3 · derivative.exercise_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F3 · derivative.expiration_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 19:02 UTC |
LAFFER ARTHUR BDirector
|
Exercise / conversionCommon Stock | 2,958 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-004226 · rdgdoc.xml · nonDerivative · entry 1 LAFFER ARTHUR B · CIK 0001090307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:00 UTC |
Constantino Edward N.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 2,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004224 · rdgdoc.xml · derivative · entry 3 Constantino Edward N. · CIK 0001498322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,958 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F3 · derivative.exercise_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F3 · derivative.expiration_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:00 UTC |
Constantino Edward N.Director
|
Exercise / conversionCommon Stock | 2,958 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-004224 · rdgdoc.xml · nonDerivative · entry 1 Constantino Edward N. · CIK 0001498322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 15,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004222 · rdgdoc.xml · derivative · entry 7 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,518 Underlying: Common Stock · 15,839 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F8 · derivative.exercise_date: On February 22, 2021, the reporting person was granted 63,357 restricted stock units. The restricted stock units vested one-fourth on February 22, 2022, and will vest one-fourth on February 22, 2023, one-fourth on February 22, 2024 and one-fourth on February 22, 2025. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F8 · derivative.expiration_date: On February 22, 2021, the reporting person was granted 63,357 restricted stock units. The restricted stock units vested one-fourth on February 22, 2022, and will vest one-fourth on February 22, 2023, one-fourth on February 22, 2024 and one-fourth on February 22, 2025. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC |
DONDERO JAMES DDirector · President · 10% owner
|
Exercise / conversionCommon Stock | 15,839 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-004222 · rdgdoc.xml · nonDerivative · entry 1 DONDERO JAMES D · CIK 0001228922 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:01 UTC |
KAVANAUGH SCOTT FDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004227 · rdgdoc.xml · derivative · entry 3 KAVANAUGH SCOTT F · CIK 0001218975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,958 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F3 · derivative.exercise_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F3 · derivative.expiration_date: On February 22, 2021, the reporting person was granted 2,958 restricted stock units which vested on February 22, 2022. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:01 UTC |
KAVANAUGH SCOTT FDirector
|
Exercise / conversionCommon Stock | 2,958 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-004227 · rdgdoc.xml · nonDerivative · entry 1 KAVANAUGH SCOTT F · CIK 0001218975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:02 UTC |
Mitts BrianDirector · See Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 5,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004228 · rdgdoc.xml · derivative · entry 4 Mitts Brian · CIK 0001514845 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,490 Underlying: Common Stock · 5,164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. F3 · derivative.exercise_date: On February 22, 2021, the reporting person was granted 20,654 restricted stock units. The restricted stock units vested one-fourth on February 22, 2022, and will vest one-fourth on February 22, 2023, one-fourth on February 22, 2024 and one-fourth on February 22, 2025. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. F3 · derivative.expiration_date: On February 22, 2021, the reporting person was granted 20,654 restricted stock units. The restricted stock units vested one-fourth on February 22, 2022, and will vest one-fourth on February 22, 2023, one-fourth on February 22, 2024 and one-fourth on February 22, 2025. Settlement will generally occur within 10 days of vesting and may at the discretion of the Compensation Committee be settled in cash. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 00:02 UTC |
Mitts BrianDirector · See Remarks
|
Exercise / conversionCommon Stock | 5,164 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-004228 · rdgdoc.xml · nonDerivative · entry 1 Mitts Brian · CIK 0001514845 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of NexPoint Real Estate Finance, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.